Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3091% below fair value
$0.57−0.02 (-3.33%)
Close on Nov 12, 2026Market cap $1.20MP/E –Yield –
Curis operating margin
Operating margin is operating income as a percentage of revenue.
Curis's operating margin for the twelve months ending Jun 30, 2026 was -203.2%. For fiscal 2025 it was -60.5%, against -408.3% the year before. The highest annual figure on record is -35.2% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -60.5% | +347.8 |
| FY2024 | Dec 31, 2024 | -408.3% | +73.9 |
| FY2023 | Dec 31, 2023 | -482.2% | +39.5 |
| FY2022 | Dec 31, 2022 | -521.7% | −126.7 |
| FY2021 | Dec 31, 2021 | -395.0% | −165.2 |
| FY2020 | Dec 31, 2020 | -229.8% | +13.7 |
| FY2019 | Dec 31, 2019 | -243.5% | +37.8 |
| FY2018 | Dec 31, 2018 | -281.3% | +221.4 |
| FY2017 | Dec 31, 2017 | -502.7% | +268.3 |
| FY2016 | Dec 31, 2016 | -771.1% | −54.1 |
| FY2015 | Dec 31, 2015 | -716.9% | −555.8 |
| FY2014 | Dec 31, 2014 | -161.2% | −98.4 |
| FY2013 | Dec 31, 2013 | -62.8% | +46.9 |
| FY2012 | Dec 31, 2012 | -109.7% | −60.9 |
| FY2011 | Dec 31, 2011 | -48.8% | −13.6 |
| FY2010 | Dec 31, 2010 | -35.2% | +81.7 |
| FY2009 | Dec 31, 2009 | -116.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 1724.0% | +1992.9 |
| Q3 FY2025 | Sep 30, 2025 | -218.0% | +142.5 |
| Q2 FY2025 | Jun 30, 2025 | -300.1% | +191.3 |
| Q1 FY2025 | Mar 31, 2025 | -426.8% | +171.0 |
| Q4 FY2024 | Dec 31, 2024 | -268.9% | +183.6 |
| Q3 FY2024 | Sep 30, 2024 | -360.5% | +76.0 |
| Q2 FY2024 | Jun 30, 2024 | -491.4% | +61.0 |
| Q1 FY2024 | Mar 31, 2024 | -597.7% | −91.6 |
| Q4 FY2023 | Dec 31, 2023 | -452.5% | −98.5 |
| Q3 FY2023 | Sep 30, 2023 | -436.6% | +9.7 |
| Q2 FY2023 | Jun 30, 2023 | -552.5% | +76.9 |
| Q1 FY2023 | Mar 31, 2023 | -506.2% | +229.5 |
| Q4 FY2022 | Dec 31, 2022 | -354.0% | +46.9 |
| Q3 FY2022 | Sep 30, 2022 | -446.2% | −115.6 |
| Q2 FY2022 | Jun 30, 2022 | -629.4% | −163.5 |
| Q1 FY2022 | Mar 31, 2022 | -735.7% | −333.7 |
| Q4 FY2021 | Dec 31, 2021 | -400.9% | −193.4 |
| Q3 FY2021 | Sep 30, 2021 | -330.6% | −158.8 |
| Q2 FY2021 | Jun 30, 2021 | -465.9% | −235.8 |
| Q1 FY2021 | Mar 31, 2021 | -402.0% | −88.9 |
| Q4 FY2020 | Dec 31, 2020 | -207.5% | +15.6 |
| Q3 FY2020 | Sep 30, 2020 | -171.8% | +14.6 |
| Q2 FY2020 | Jun 30, 2020 | -230.1% | +63.2 |
| Q1 FY2020 | Mar 31, 2020 | -313.1% | +1.4 |
| Q4 FY2019 | Dec 31, 2019 | -223.1% | −36.3 |
| Q3 FY2019 | Sep 30, 2019 | -186.4% | +39.0 |
| Q2 FY2019 | Jun 30, 2019 | -293.3% | +40.1 |
| Q1 FY2019 | Mar 31, 2019 | -314.5% | +86.9 |
| Q4 FY2018 | Dec 31, 2018 | -186.9% | +31.6 |
| Q3 FY2018 | Sep 30, 2018 | -225.4% | +366.7 |
| Q2 FY2018 | Jun 30, 2018 | -333.3% | +302.7 |
| Q1 FY2018 | Mar 31, 2018 | -401.5% | +304.9 |
| Q4 FY2017 | Dec 31, 2017 | -218.5% | +237.2 |
| Q3 FY2017 | Sep 30, 2017 | -592.1% | +987.7 |
| Q2 FY2017 | Jun 30, 2017 | -636.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -706.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -455.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -1579.8% | – |
See a number that looks wrong?